Suchergebnisse - (Subject:"Immunologic Factors")

PubPharm (5)

1

Adverse effects under immune checkpoint inhibitors on (18F)FDG PET/CT imaging

enthalten in: The quarterly journal of nuclear medicine and molecular imaging | September

von Sachpekidis, C. | Hassel, J. | Dimitrakopoulou-Strauss, A.

2

High-Dose Rituximab and Early Remission in PLA2R1-Related Membranous Nephropathy

enthalten in: Clinical journal of the American Society of Nephrology : CJASN | 2019

von Seitz-Polski, B. | Dahan, K. | Debiec, H. | +10

CommentIn: Clin J Am Soc Nephrol. 2019 Aug 7;14(8):1122-1124. - PMID 31340980

3

Mycophenolic Acid Pharmacokinetics and Relapse in Children with Steroid-Dependent Idiopathic Nephrotic Syndrome

enthalten in: Clinical journal of the American Society of Nephrology : CJASN | 2016

von Tellier, S. | Dallocchio, A. | Guigonis, V. | +12

4

T Lymphocyte Activation Markers as Predictors of Responsiveness to Rituximab among Patients with FSGS

enthalten in: Clinical journal of the American Society of Nephrology : CJASN | 2016

von Chan, C. | Liu, I. | Resontoc, L. | +8

5

Eculizumab for atypical hemolytic-uremic syndrome

enthalten in: The New England journal of medicine | January 29, 2009

von Nürnberger, J. | Philipp, T. | Witzke, O. | +8

1
[1]